MK 0431 phosphate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

MK 0431 Phosphate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Granules Sitagliptin Phosphate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

MK 0431 phosphate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

155 API Suppliers, 66 USDMF, 25 CEP/COS, 6 JDMF, 24 EU WC, 6 KDMF, 42 NDC API, 98 Listed Suppliers, $ API Reference Price

155 API Suppliers
66 USDMF
25 CEP/COS
6 JDMF
24 EU WC
6 KDMF
42 NDC API
98 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

55 Intermediates Suppliers

55 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

551 FDF Dossiers, 65 FDA Orange Book, 231 Europe, 80 Australia, 11 South Africa, 164 Listed Dossiers

551 FDF Dossiers
65 FDA Orange Book
231 Europe
80 Australia
11 South Africa
164 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - 1GM;EQ 50MG BASE, TABLET;ORAL - 500MG;EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - 1GM;EQ 50MG BASE
TABLET;ORAL - 500MG;EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 Minakem, 2 SPI Pharma, 2 Seqens, 11 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 30 Controlled & Modified Release, 23 Lubricants & Glidants, 19 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Thickeners and Stabilizers, 13 Granulation, 11 Topical, 10 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 API Stability Enhancers, 7 Solubilizers, 6 Taste Masking, 5 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Emulsifying Agents, 4 Parenteral, 4 Vegetarian Capsules, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

52 Coating Systems & Additives
35 Fillers, Diluents & Binders
30 Controlled & Modified Release
23 Lubricants & Glidants
19 Disintegrants & Superdisintegrants
18 Direct Compression
17 Thickeners and Stabilizers
13 Granulation
11 Topical
10 Co-Processed Excipients
8 Film Formers & Plasticizers
8 API Stability Enhancers
7 Solubilizers
6 Taste Masking
5 Chewable & Orodispersible Aids
5 Empty Capsules
5 Coloring Agents
4 Emulsifying Agents
4 Parenteral
4 Vegetarian Capsules
3 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

16 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 130 NEWS #PharmaBuzz

16 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
130 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 200 Finished Drug Prices, 17 Annual Reports

2 US Medicaid Prescriptions
200 Finished Drug Prices
17 Annual Reports

MARKET PLACE

41 APIs, 20 FDF Dossiers

41 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

45 US Patents, 16 US Exclusivities, 9 Health Canada Patents

45 US Patents
16 US Exclusivities
9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 9 Others

2 USP
9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 658 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

45 All

01 18MERCK SHARP DOHME

02 24MSD SUB MERCK

03 3ZYDUS LIFESCIENCES

filter Patent Number Reset all filters

45 All

01 167326708

02 28080580

03 28414921

04 29308204

05 29439901

06 310925871

07 167326708*PED

08 28414921*PED

filter API Patent Reset all filters

45 All

01 18Y

02 27Blank

filter FDF Patent Reset all filters

45 All

01 25Y

02 20Blank

filter Expiration Date Reset all filters

45 All

01 62026-04-11

02 62026-10-11

03 102026-11-24

04 102027-05-24

05 22028-07-21

06 22029-01-21

07 22030-07-13

08 42030-10-21

09 32035-02-25

drl Sitagliptin Phosphate

Product Main Page

01

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MERCK SHARP DOHME

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-04-11

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202343

Patent Use Code : U-1188

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-04-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21995

Patent Use Code : U-802

Delist Requested :

Patent Use Description : METHOD OF TREATING TYP...

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MERCK SHARP DOHME

SITAGLIPTIN PHOSPHATE

Pharmtech & Ingredients

Not Confirmed

MERCK SHARP DOHME

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-24

SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21995

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-05-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?